Mode
Text Size
Log in / Sign up

Clinical Trial Search

Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.

Phase
Intervention
Population
Results posted

65,437 trials

Phase 3 N=1,094 Natalizumab Re-Initiation of Dosing

Multiple Sclerosis, Relapsing-Remitting
Primary: Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious AEs (SAEs) — 826; 487; 66; 161 participants
Biogen Results Jan 2010 5.6% serious AE View details